| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chair of Clinical Immunology and Allergy (C.B., C.D.P., R.Z.), Chair and Division of Endocrinology (F.M.), Department of Medical and Surgical Sciences, University of Padova, I-35128, Padova, Italy
Correspondence: Address all correspondence and requests for reprints to: Professor Corrado Betterle, M.D., Chair of Clinical Immunology and Allergy, Department of Medical and Surgical Sciences, University of Padova, Via Ospedale 105, 35128 Padova, Italy. E-mail: corrado.betterle{at}unipd.it
Recent progress in the understanding of autoimmune adrenal disease, including a detailed analysis of a group of patients with Addisons disease (AD), has been reviewed. Criteria for defining an autoimmune disease and the main features of autoimmune AD (history, prevalence, etiology, histopathology, clinical and laboratory findings, cell-mediated andhumoral immunity, autoantigens and their autoepitopes, genetics, animal models, associated autoimmune diseases, pathogenesis, natural history, therapy) have been described. Furthermore, the autoimmune polyglandular syndromes (APS) associated with AD (revised classification, animal models, genetics, natural history) have been discussed.
Of Italian patients with primary AD (n = 317), 83% had autoimmune AD. At the onset, all patients with autoimmune AD (100%) had detectable adrenal cortex and/or steroid 21-hydroxylase autoantibodies. In the course of natural history of autoimmune AD, the presence of adrenal cortex and/or steroid 21-hydroxylase autoantibodies identified patients at risk to develop AD. Different risks of progression to clinical AD were found in children and adults, and three stages of subclinical hypoadrenalism have been defined. Normal or atrophic adrenal glands have been demonstrated by imaging in patients with clinical or subclinical AD.
Autoimmune AD presented in four forms: as APS type 1 (13% of the patients), APS type 2 (41%), APS type 4 (5%), and isolated AD (41%). There were differences in genetics, age at onset, prevalence of adrenal cortex/21-hydroxylase autoantibodies, and associated autoimmune diseases in these groups. "Incomplete" forms of APS have been identified demonstrating that APS are more prevalent than previously reported.
A varied prevalence of hypergonadotropic hypogonadism in patients with AD and value of steroid-producing cells autoantibodies reactive with steroid 17
-hydroxylase or P450 side-chain cleavage enzyme as markers of this disease has been discussed. In addition, the prevalence, characteristic autoantigens, and autoantibodies of minor autoimmune diseases associated with AD have been described.
Imaging of adrenal glands, genetic tests, and biochemical analysis have been shown to contribute to early and correct diagnosis of primary non-autoimmune AD in the cases of hypoadrenalism with undetectable adrenal autoantibodies. An original flow chart for the diagnosis of AD has been proposed.
This article has been cited by other articles:
![]() |
M. Alimohammadi, P. Bjorklund, A. Hallgren, N. Pontynen, G. Szinnai, N. Shikama, M. P. Keller, O. Ekwall, S. A. Kinkel, E. S. Husebye, et al. Autoimmune Polyendocrine Syndrome Type 1 and NALP5, a Parathyroid Autoantigen N. Engl. J. Med., March 6, 2008; 358(10): 1018 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. M. De Block, I. H. De Leeuw, and L. F. Van Gaal Autoimmune Gastritis in Type 1 Diabetes: A Clinically Oriented Review J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 363 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Reimand, J. Perheentupa, M. Link, K. Krohn, P. Peterson, and R. Uibo Testis-expressed protein TSGA10 an auto-antigen in autoimmune polyendocrine syndrome type I Int. Immunol., January 1, 2008; 20(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Pires, P. K. Meherji, R. R. Vaidya, F. R. Parikh, M. N. Ghosalkar, and V. V. Khole Specific and Sensitive Immunoassays Detect Multiple Anti-ovarian Antibodies in Women With Infertility J. Histochem. Cytochem., December 1, 2007; 55(12): 1181 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani Role of Chemokines in Endocrine Autoimmune Diseases Endocr. Rev., August 1, 2007; 28(5): 492 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Manetti, I. Lupi, L. L. Morselli, S. Albertini, M. Cosottini, L. Grasso, M. Genovesi, G. Pinna, S. Mariotti, F. Bogazzi, et al. Prevalence and Functional Significance of Antipituitary Antibodies in Patients with Autoimmune and Non-Autoimmune Thyroid Diseases J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2176 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gavanescu, B. Kessler, H. Ploegh, C. Benoist, and D. Mathis Loss of Aire-dependent thymic expression of a peripheral tissue antigen renders it a target of autoimmunity PNAS, March 13, 2007; 104(11): 4583 - 4587. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Candeloro, C. B. Voltattorni, R. Perniola, M. Bertoldi, C. Betterle, M. Mannelli, R. Giordano, A. De Bellis, C. Tiberti, S. Laureti, et al. Mapping of Human Autoantibody Epitopes on Aromatic L-Amino Acid Decarboxylase J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1096 - 1105. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, and G. Johannsson Premature Mortality in Patients with Addison's Disease: A Population-Based Study J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4849 - 4853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Giordano, M. Balbo, A. Picu, L. Bonelli, R. Berardelli, A. Falorni, E. Ghigo, and E. Arvat Corticotrope hypersecretion coupled with cortisol hypo-responsiveness to stimuli is present in patients with autoimmune endocrine diseases: evidence for subclinical primary hypoadrenalism? Eur. J. Endocrinol., September 1, 2006; 155(3): 421 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Bellis, M. Salerno, M. Conte, C. Coronella, G. Tirelli, M. Battaglia, V. Esposito, G. Ruocco, G. Bellastella, A. Bizzarro, et al. Antipituitary Antibodies Recognizing Growth Hormone (GH)-Producing Cells in Children with Idiopathic GH Deficiency and in Children with Idiopathic Short Stature J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2484 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Coco, C. Dal Pra, F. Presotto, M. P. Albergoni, C. Canova, B. Pedini, R. Zanchetta, S. Chen, J. Furmaniak, B. Rees Smith, et al. Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1637 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Tran Incidental Adrenal Insufficiency JAMA, March 8, 2006; 295(10): 1124 - 1124. [Full Text] [PDF] |
||||
![]() |
D Shepshelovich and Y Shoenfeld Prediction and prevention of autoimmune diseases: additional aspects of the mosaic of autoimmunity Lupus, March 1, 2006; 15(3): 183 - 190. [Abstract] [PDF] |
||||
![]() |
C. Betterle, F. Lazzarotto, A. C. Spadaccino, D. Basso, M. Plebani, B. Pedini, S. Chiarelli, and M. Albergoni Celiac disease in North Italian patients with autoimmune Addison's disease Eur. J. Endocrinol., February 1, 2006; 154(2): 275 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Miguel, S. Chen, L. Nikfarjam, S. Kominami, B. Carpenter, C. Dal Pra, C. Betterle, R. Zanchetta, T. Nakamatsu, M. Powell, et al. Analysis of the interaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling Eur. J. Endocrinol., December 1, 2005; 153(6): 949 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Presotto, F. Fornasini, C. Betterle, G. Federspil, and M. Rossato Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature Eur. J. Endocrinol., October 1, 2005; 153(4): 507 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lindsay and L. K. Nieman The Hypothalamic-Pituitary-Adrenal Axis in Pregnancy: Challenges in Disease Detection and Treatment Endocr. Rev., October 1, 2005; 26(6): 775 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Goswami and G. S. Conway Premature ovarian failure Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Barker, J. Yu, L. Yu, J. Wang, D. Miao, F. Bao, E. Hoffenberg, J. C. Nelson, P. A. Gottlieb, M. Rewers, et al. Autoantibody "Subspecificity" in Type 1 Diabetes: Risk for organ-specific autoimmunity clusters in distinct groups Diabetes Care, April 1, 2005; 28(4): 850 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rotondi, A. Falorni, A. De Bellis, S. Laureti, P. Ferruzzi, P. Romagnani, A. Buonamano, E. Lazzeri, C. Crescioli, M. Mannelli, et al. Elevated Serum Interferon-{gamma}-Inducible Chemokine-10/CXC Chemokine Ligand-10 in Autoimmune Primary Adrenal Insufficiency and in Vitro Expression in Human Adrenal Cells Primary Cultures after Stimulation with Proinflammatory Cytokines J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2357 - 2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Nikfarjam, S Kominami, T Yamazaki, S Chen, R Hewer, C Dal Pra, T Nakamatsu, C Betterle, R Zanchetta, B Rees Smith, et al. Mechanism of inhibition of cytochrome P450 C21 enzyme activity by autoantibodies from patients with Addison's disease Eur. J. Endocrinol., January 1, 2005; 152(1): 95 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Piccoli, E. Mezza, M. Burdese, M. Terzolo, G. Grassi, F. Bermond, G. Soragna, M. Gai, F. Dani, A. Jeantet, et al. Progression of renal failure without proteinuria in a patient with type 1 diabetes Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3197 - 3199. [Full Text] [PDF] |
||||
![]() |
C. Barnard, R. Kanani, and J. N. Friedman Her tongue tipped us off... Can. Med. Assoc. J., August 31, 2004; 171(5): 451 - 451. [Full Text] [PDF] |
||||
![]() |
G. S. Eisenbarth and P. A. Gottlieb Autoimmune Polyendocrine Syndromes N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079. [Full Text] [PDF] |
||||
![]() |
A. Falorni, S. Laureti, A. De Bellis, R. Zanchetta, C. Tiberti, G. Arnaldi, V. Bini, P. Beck-Peccoz, A. Bizzarro, F. Dotta, et al. Italian Addison Network Study: Update of Diagnostic Criteria for the Etiological Classification of Primary Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1598 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Giordano, M. Pellegrino, S. Oleandri, M. Baldi, M. Balbo, S. Laureti, A. Falorni, E. Ghigo, and E. Arvat Adrenal Sensitivity to Adrenocorticotropin 1-24 Is Reduced in Patients with Autoimmune Polyglandular Syndrome J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 675 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dittmar and G. J. Kahaly Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2983 - 2992. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gianani and G. S. Eisenbarth Autoimmunity to Gastrointestinal Endocrine Cells in Autoimmune Polyendocrine Syndrome Type I J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1442 - 1444. [Full Text] [PDF] |
||||
![]() |
R. Silverstein and D. C. Johnson Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis J. Leukoc. Biol., April 1, 2003; 73(4): 417 - 427. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |